PSP
NVO

Principal Street Partners’s Novo Nordisk NVO Stock Holding History

Principal Street Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322K Buy
6,721
+1,064
+19% +$45.7K 0.05% 180
2026
Q1 		$208K Sell
5,657
-2,077
-27% -$98.4K 0.03% 226
2025
Q4 		$393K Sell
7,734
-1,245
-14% -$63.7K 0.07% 148
2025
Q3 		$498K Sell
8,979
-16,804
-65% -$984K 0.08% 132
2025
Q2 		$1.78M Buy
25,783
+16,270
+171% +$1.11M 0.17% 81
2025
Q1 		$661K Hold
9,513
– – 0.12% 105
2024
Q4 		$818K Buy
9,513
+235
+3% +$25.4K 0.16% 89
2024
Q3 		$1.32M Sell
9,278
-10
-0.1% -$1.33K 0.22% 73
2024
Q2 		$1.33M Buy
9,288
+10
+0.1% +$1.32K 0.24% 65
2024
Q1 		$1.19M Sell
9,278
-1,481
-14% -$176K 0.23% 69
2023
Q4 		$1.11M Sell
10,759
-10,759
-50% -$1.06M 0.27% 64
2023
Q3 		$1.96M Buy
21,518
+11,348
+112% +$1,000K 0.39% 60
2023
Q2 		$823K Sell
10,170
-2,752
-21% -$225K 0.2% 79
2023
Q1 		$1.04M Buy
12,922
+272
+2% +$19.3K 0.26% 65
2022
Q4 		$856K Buy
12,650
+228
+2% +$13.4K 0.22% 74
2022
Q3 		$619K Buy
12,422
+698
+6% +$37.4K 0.17% 106
2022
Q2 		$653K Sell
11,724
-2,318
-17% -$129K 0.17% 97
2022
Q1 		$787K Buy
+14,042
New +$721K 0.18% 94
2021
Q4 		– Sell
-12,280
Closed -$589K – 206
2021
Q3 		$589K Buy
12,280
+2,882
+31% +$139K 0.16% 105
2021
Q2 		$394K Buy
9,398
+660
+8% +$25.6K 0.1% 139
2021
Q1 		$299K Hold
8,738
– – 0.04% 173
2020
Q4 		$305K Hold
8,738
– – 0.09% 143
2020
Q3 		$303K Buy
+8,738
New +$291K 0.11% 124
2020
Q2 		– Sell
-12,300
Closed -$375K – 139
2020
Q1 		$375K Hold
12,300
– – 0.16% 97
2019
Q4 		$356K Hold
12,300
– – 0.08% 152
2019
Q3 		$318K Buy
12,300
+32
+0.3% +$809 0.08% 151
2019
Q2 		$313K Buy
+12,268
New +$303K 0.17% 121

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Principal Street Partners's NVO Position: Q2 2026 in Review

Principal Street Partners increased its Novo Nordisk (NVO) stake by 19% in Q2 2026, buying an estimated $45.7K and bringing the position to 6,721 shares worth $322K. The position accounts for 0.05% of the portfolio, ranked #180.

Principal Street Partners first reported a position in NVO in Q2 2019 and has held it in 27 quarters since. The position peaked at $1.96M in Q3 2023. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Principal Street Partners held 6,721 shares of Novo Nordisk worth $322K as of Q2 2026.
  • Principal Street Partners bought 1,064 Novo Nordisk shares in Q2 2026, an estimated $45.7K.
  • Novo Nordisk made up 0.05% of Principal Street Partners's portfolio in Q2 2026, its #180 holding.
  • Principal Street Partners first reported a position in Novo Nordisk in Q2 2019 and has held it in 27 quarters since.
  • Principal Street Partners's Novo Nordisk position peaked at $1.96M in Q3 2023.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Principal Street Partners's 13F filing for Q2 2026, filed 14 Aug 2026.